The Cigna Group (NYSE:CI) Given New $390.00 Price Target at Morgan Stanley

08 May 2025, 02:54 by Scott Moore · The Cerbat Gem

The Cigna Group (NYSE:CI – Free Report) had its price target boosted by Morgan Stanley from $379.00 to $390.00 in a research note published on Monday, MarketBeat reports. The brokerage currently has an overweight rating on the health services provider’s stock.

Several other equities analysts have also recently weighed in on the company. Truist Financial raised their price objective on The Cigna Group from $375.00 to $385.00 and gave the company a “buy” rating in a report on Friday, April 11th. Guggenheim restated a “buy” rating and issued a $388.00 price target (up from $384.00) on shares of The Cigna Group in a research note on Monday. Cantor Fitzgerald upped their price objective on The Cigna Group from $350.00 to $365.00 and gave the stock an “overweight” rating in a research note on Thursday, March 20th. StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, April 8th. Finally, Barclays upped their price target on shares of The Cigna Group from $339.00 to $382.00 and gave the stock an “overweight” rating in a research report on Monday. Two investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $378.22.

Check Out Our Latest Analysis on CI

The Cigna Group Trading Up 0.2 %

NYSE CI opened at $334.55 on Monday. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The stock’s 50 day moving average price is $324.90 and its two-hundred day moving average price is $309.92. The stock has a market capitalization of $89.37 billion, a price-to-earnings ratio of 27.33, a PEG ratio of 0.98 and a beta of 0.47.

The Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping analysts’ consensus estimates of $6.35 by $0.39. The business had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The firm’s revenue for the quarter was up 14.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.47 earnings per share. As a group, analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group’s dividend payout ratio is 33.44%.

Insiders Place Their Bets

In other The Cigna Group news, insider Nicole S. Jones sold 4,904 shares of The Cigna Group stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the completion of the transaction, the insider now directly owns 29,421 shares of the company’s stock, valued at $9,065,198.52. The trade was a 14.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO David Cordani sold 26,527 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,751 shares of company stock worth $13,603,991 in the last 90 days. Company insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On The Cigna Group

Several hedge funds and other institutional investors have recently modified their holdings of CI. Sterling Financial Group Inc. acquired a new stake in shares of The Cigna Group in the 4th quarter valued at approximately $4,367,000. Principal Financial Group Inc. boosted its position in The Cigna Group by 3.6% in the third quarter. Principal Financial Group Inc. now owns 323,911 shares of the health services provider’s stock valued at $112,216,000 after buying an additional 11,228 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. grew its stake in shares of The Cigna Group by 1.1% during the fourth quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 75,837 shares of the health services provider’s stock worth $20,942,000 after buying an additional 858 shares during the last quarter. Valley Wealth Managers Inc. increased its holdings in shares of The Cigna Group by 2.8% during the fourth quarter. Valley Wealth Managers Inc. now owns 56,933 shares of the health services provider’s stock worth $15,721,000 after buying an additional 1,548 shares in the last quarter. Finally, KBC Group NV lifted its stake in shares of The Cigna Group by 1.5% in the 4th quarter. KBC Group NV now owns 550,638 shares of the health services provider’s stock valued at $152,053,000 after acquiring an additional 8,077 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Company Profile

(Get Free Report)